Mirko Uljarević is clinical assistant professor of psychiatry and behavioral sciences at Stanford University in California.
Mirko Uljarević
Senior Research Fellow
School of Psychological Sciences at the University of Melbourne in Victoria, Australia
From this contributor
Teasing apart insistence on sameness with Mirko Uljarević
The hallmark autism trait has multiple facets, Uljarević and his colleagues have found.
Teasing apart insistence on sameness with Mirko Uljarević
By
Lauren Schenkman
30 October 2023 | 6 min read
In search of ‘social’ subtypes of autism
Grouping autistic people based on their social abilities may reveal subtypes of the condition.
In search of ‘social’ subtypes of autism
By
Thomas Frazier, Mirko Uljarević
21 July 2020 | 5 min read
Explore more from The Transmitter
Supported by a $40 million NIH grant, Yale brain shuttle technology raises questions
Yale University claims its STEP platform might be able to deliver gene-editing tools into the brain via multiple routes. Researchers are eager to see more.
Supported by a $40 million NIH grant, Yale brain shuttle technology raises questions
Yale University claims its STEP platform might be able to deliver gene-editing tools into the brain via multiple routes. Researchers are eager to see more.
By
Natalia Mesa
3 June 2026 | 11 min read
What counts as a ‘naturalistic’ behavior?
Nedah Nemati explains how neuroscience methods and the lived experience of the scientists themselves shape how we define the behaviors we seek to explain.
What counts as a ‘naturalistic’ behavior?
Nedah Nemati explains how neuroscience methods and the lived experience of the scientists themselves shape how we define the behaviors we seek to explain.
By
Paul Middlebrooks
3 June 2026 | 1 min read
Allen Institute sets sights on treatments for five brain diseases
The Brain Health Accelerator program aims to harness single-cell transcriptomics and cell-type-specific genetic tools to develop treatments for Alzheimer’s, Huntington’s and Parkinson’s diseases, Lewy body dementia and ALS.
Allen Institute sets sights on treatments for five brain diseases
The Brain Health Accelerator program aims to harness single-cell transcriptomics and cell-type-specific genetic tools to develop treatments for Alzheimer’s, Huntington’s and Parkinson’s diseases, Lewy body dementia and ALS.
By
Calli McMurray
2 June 2026 | 5 min read